Aurora Cannabis (NYSE:ACB) initiated with Neutral rating at Compass Point. Shares down a fraction premarket.
Rhythm Pharmaceuticals (NASDAQ:RYTM) initiated with Buy rating and $35 (66% upside) price target at Canaccord Genuity.
PolarityTE (NASDAQ:PTE) initiated with Buy rating and $8 (45% upside) price target at H.C. Wainwright. Shares up 2% premarket.
Protagonist Therapeutics (NASDAQ:PTGX) initiated with Buy rating and $23 (79% upside) price target at H.C. Wainwright.
Replimune (NASDAQ:REPL) initiated with Buy rating and $26 (90% upside) price target at H.C. Wainwright.
Array BioPharma (NASDAQ:ARRY) downgraded to Neutral with a $48 (2% upside) price target at Cantor Fitzgerald.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.